Skip to content

Clinical trials

Completed Phase 1/2 Adenocarcinoma of Lung trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Phase: Phase 1/2 Status: Completed Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20081
20112
20141
20171
20181
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center2
Radiation Therapy Oncology Group2
AIO-Studien-gGmbH1
Mayo Clinic1
National Cancer Institute (NCI)1
NewLink Genetics Corporation1
Northwestern University1
Shanghai Chest Hospital1
Wake Forest University Health Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung11
Carcinoma, Non-Small-Cell Lung6
Lung Neoplasms6
Adenocarcinoma1
Carcinoma, Large Cell1
Carcinoma, Squamous Cell1
Mesothelioma1
Neoplasm Metastasis1
Pancreatic Neoplasms1
Small Cell Lung Carcinoma1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.